Odysii uses $15M to light up digital signs in the U.S.
Odysii, developer of software that can distribute content to thousands of digital signs at the same time, will apply a new $15 million fund expansion to the U.S. The Israeli company, previously called TVeez, has mostly kept its sights on Europe and South America until now.
In fact, it has already kicked off its roll out to the U.S. with the establishment of a headquarters in New York and the hiring of Jeff Gattis, director of… Continue Reading
Life-science briefing: Wednesday, March 19, 2008
TODAY’S HEADLINES:
Paris-based Stentys takes $18M for “bifurcated” stents (release)
Blood analyzer IntelliDx raises $22M (PDF release)
Cancer-test biotech Calderome changes name to VeraCyte (VentureWire)
Predictive Biosciences names Peter Klemm as CEO (release)
Paris-based Stentys takes $18M for “bifurcated” stents – Stentys, a Paris-based medical device maker, raised $18 million in a second funding round. The company is developing “bifurcated” stents intended to prop open clogged arteries at blood-vessel junctions.
The startup said the funding will allow it to complete clinical trials… Continue Reading